Philips To Focus On Community And Rural Healthcare In China
This article was originally published in PharmAsia News
Executive Summary
Philips will focus on China's community and rural healthcare in the next three years. The firm will provide health welfare collaboration projects with $1 million in funding, along with products, technology and training support, to promote the country's community healthcare development, which includes the recently started community chronic disease management program with the local Red Cross Society. Top priority will be given to rural and less-developed western regions of China. The firm is setting up a distribution system for the market and investing RMB 2 million in a three-year rural healthcare program. Philips' healthcare business posted double-digit growth in Q1 of 2009 in China. (Click here for more - Chinese Language)
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.